🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Dev Prasad

Stock Analyst at Lucid Capital

(4.40)
# 1,282
Out of 5,152 analysts
24
Total ratings
38.1%
Success rate
41.2%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Dev Prasad

Cue Biopharma
Nov 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.50
Upside: -
Faeth Therapeutics
Nov 9, 2026
Reiterated: Buy
Price Target: $59
Current: $8.69
Upside: +578.94%
Acumen Pharmaceuticals
Nov 2, 2026
Downgraded: Hold
Price Target: $6 → $1
Current: $0.1933
Upside: +417.33%
Turn Therapeutics
Sep 24, 2026
Initiated Coverage: Buy
Price Target: $24
Current: $8.64
Upside: +177.78%
Genelux
Sep 16, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $2.28
Upside: +689.47%
Adlai Nortye Group
Sep 8, 2026
Initiated Coverage: Buy
Price Target: $49
Current: $9.06
Upside: +440.84%
Eloxx Pharmaceuticals
Aug 20, 2026
Initiated Coverage: Buy
Price Target: $38
Current: $10.65
Upside: +256.81%
Polaryx Therapeutics
Jul 27, 2026
Initiated Coverage: Buy
Price Target: $7
Current: $1.51
Upside: +363.58%
Quoin Pharmaceuticals
May 4, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $3.36
Upside: +793.10%
Palvella Therapeutics
Dec 15, 2025
Reiterated: Buy
Price Target: $49 → $212
Current: $145.77
Upside: +45.43%
Reiterated: Buy
Price Target: $24
Current: $1.09
Upside: n/a
Initiated Coverage: Buy
Price Target: $19
Current: $2.89
Upside: n/a
Initiated Coverage: Buy
Price Target: $4.00
Current: $0.22
Upside: n/a
Downgraded: Hold
Price Target: $1
Current: $3.69
Upside: n/a
Initiated Coverage: Buy
Price Target: $5
Current: $4.08
Upside: n/a
Initiated Coverage: Buy
Price Target: $9
Current: $2.18
Upside: n/a
Initiated Coverage: Buy
Price Target: $36
Current: $1.25
Upside: n/a
Initiated Coverage: Buy
Price Target: $24
Current: $6.75
Upside: n/a
Initiated Coverage: Buy
Price Target: $13
Current: $1.17
Upside: n/a
Initiated Coverage: Buy
Price Target: $6
Current: $0.801
Upside: n/a